NCT00111800 - A New Oral Treatment For Type II Diabetes Mellitus | Biotech Hunter

Enrollment

375

Participants

Timeline

Start Date

April 28, 2005

Primary Completion Date

July 1, 2006

Study Completion Date

July 21, 2006

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Placebo

Placebo capsules which were white, opaque capsules with no identifying markings, containing white to off-white beads.

DRUG

DEN 2.5 mg

DEN 2.5 mg capsules which were white, opaque capsules with no identifying markings, containing white to off-white beads.

DRUG

DEN 7.5 mg

DEN 7.5 mg capsules which were white, opaque capsules with no identifying markings, containing white to off-white beads.

DRUG

DEN 15 mg

DEN 15 mg capsules which were white, opaque capsules with no identifying markings, containing white to off-white beads.

DRUG

DEN 30 mg

DEN 30 mg capsules which were white, opaque capsules with no identifying markings, containing white to off-white beads.

DRUG

DEN 45 mg

DEN 45 mg capsules which were white, opaque capsules with no identifying markings, containing white to off-white beads.

Trial Locations (109)

12208

GSK Investigational Site, Albany

13210

GSK Investigational Site, Syracuse

13790

GSK Investigational Site, Johnson City

14209

GSK Investigational Site, Buffalo

14642

GSK Investigational Site, Rochester

15025

GSK Investigational Site, Jefferson Hills

15127

GSK Investigational Site, Melíssia

15143

GSK Investigational Site, Sewickley

19500

GSK Investigational Site, Lávrio

20745

GSK Investigational Site, Oxon Hill

21255

GSK Investigational Site, Tostedt

21335

GSK Investigational Site, Lüneburg

22015

GSK Investigational Site, Burke

27612

GSK Investigational Site, Raleigh

27710

GSK Investigational Site, Durham

29201

GSK Investigational Site, Columbia

30066

GSK Investigational Site, Marietta

30308

GSK Investigational Site, Atlanta

33021

GSK Investigational Site, Hollywood

33126

GSK Investigational Site, Miami

37431

GSK Investigational Site, Bad Lauterberg im Harz

37660

GSK Investigational Site, Kingsport

45246

GSK Investigational Site, Cincinnati

45429

GSK Investigational Site, Kettering

46004

GSK Investigational Site, Liberec

46202

GSK Investigational Site, Indianapolis

55116

GSK Investigational Site, Mainz

55218

GSK Investigational Site, Ingelheim

55545

GSK Investigational Site, Bad Kreuznach

55624

GSK Investigational Site, Rhaunen

60607

GSK Investigational Site, Chicago

63067

GSK Investigational Site, Offenbach

63073

GSK Investigational Site, Offenbach

65779

GSK Investigational Site, Kelkheim

67346

GSK Investigational Site, Speyer

69120

GSK Investigational Site, Heidelberg

69245

GSK Investigational Site, Bammental

69434

GSK Investigational Site, Hirschhorn

69469

GSK Investigational Site, Weinheim

70210

GSK Investigational Site, Kuopio

70584

GSK Investigational Site, Sunset

71409

GSK Investigational Site, Heraklion, Crete

73326

GSK Investigational Site, Deggingen

74889

GSK Investigational Site, Sinsheim

75230

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

76017

GSK Investigational Site, Arlington

77654

GSK Investigational Site, Offenburg

77971

GSK Investigational Site, Kippenheim

78126

GSK Investigational Site, Königsfeld im Schwarzwald

78237

GSK Investigational Site, San Antonio

78333

GSK Investigational Site, Stockach

80220

GSK Investigational Site, Denver

83527

GSK Investigational Site, Haag

84102

GSK Investigational Site, Salt Lake City

85635

GSK Investigational Site, Höhenkirchen-Siegertsbrunn

89048

GSK Investigational Site, Pahrump

89106

GSK Investigational Site, Las Vegas

90100

GSK Investigational Site, Oulu

90806

GSK Investigational Site, Long Beach

91105

GSK Investigational Site, Pasadena

96813

GSK Investigational Site, Honolulu

98226

GSK Investigational Site, Bellingham

98403

GSK Investigational Site, Tacoma

98664

GSK Investigational Site, Vancouver

500366

GSK Investigational Site, Brasov

V3K 3P4

GSK Investigational Site, Coquitlam

R3E 3P4

GSK Investigational Site, Winnipeg

A0G 1G0

GSK Investigational Site, Bay Roberts

L6T 3T1

GSK Investigational Site, Brampton

M4R 2G4

GSK Investigational Site, Toronto

M9W 4L6

GSK Investigational Site, Toronto

N2J 1C4

GSK Investigational Site, Waterloo

J8Y 6S8

GSK Investigational Site, Gatineau

J7J 2K8

GSK Investigational Site, Mirabel

H9R 4S3

GSK Investigational Site, Pointe-Claire

G1W 4R4

GSK Investigational Site, Sainte-Foy

J1H 4J6

GSK Investigational Site, Sherbrooke

656 51

GSK Investigational Site, Brno

350 02

GSK Investigational Site, Cheb

370 87

GSK Investigational Site, České Budějovice

128 21

GSK Investigational Site, Prague

150 05

GSK Investigational Site, Prague

158 00

GSK Investigational Site, Prague

674 01

GSK Investigational Site, Třebíč

00260

GSK Investigational Site, Helsinki

01129

GSK Investigational Site, Dresden

01219

GSK Investigational Site, Dresden

01705

GSK Investigational Site, Freital

01796

GSK Investigational Site, Pirna

01762

GSK Investigational Site, Schmiedeberg

115 26

GSK Investigational Site, Athens

546 42

GSK Investigational Site, Thessaloniki

551 32

GSK Investigational Site, Thessaloniki

564 29

GSK Investigational Site, Thessaloniki

564 34

GSK Investigational Site, Thessaloniki

LV 3001

GSK Investigational Site, Jelgava

LV 5001

GSK Investigational Site, Ogre

LV 1002

GSK Investigational Site, Riga

LV1002

GSK Investigational Site, Riga

LV1079

GSK Investigational Site, Riga

LV 3201

GSK Investigational Site, Talsi

LV 4201

GSK Investigational Site, Valmiera

00716

GSK Investigational Site, Ponce

020045

GSK Investigational Site, Bucharest

020475

GSK Investigational Site, Bucharest

SE-413 45

GSK Investigational Site, Gothenburg

SE-205 02

GSK Investigational Site, Malmo

SE-182 88

GSK Investigational Site, Stockholm